Monday, January 4, 2016

Baxalta, Symphogen to Collaborate on Cancer Treatments

Baxalta and privately held Symphogen said they will work together on a €1.4 billion immuno-oncology collaboration

from WSJ.com: US Business http://ift.tt/1IMqUFn
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)